(Q78551700)
Statements
Safety of various dosage regimens during induction of sublingual immunotherapy. A preliminary study (English)
M Grosclaude
P Bouillot
R Alt
F Leynadier
P Scheinmann
P Rufin
D Basset
R Fadel
1 November 2002